The question coming from everywhere is the same: "CACR11 at R$ 18: is it a steal or a trap?" The unit closed on 07/20/2026 at R$ 18.13—an absolute all-time low—after plunging 18.6% in seven days and 30.6% in thirty. The official book value still reads R$ 98.87 per unit. On screen, that translates to a P/B ratio of 0.18: an 82% "discount." This is where unitholders either delude themselves or protect their capital. This report pulls no punches. Let's look at the numbers.
If you want to understand the origin of the turmoil—administrator BRL Trust's resignation on 07/07—read our Analysis of BRL Trust's Resignation (07/10) first. Here the focus is elsewhere: fair value, position sizing, and distributions.
The Current Picture
Chronology of the July Bleed
This wasn't a single bad day. It was a cascading drop with no support floor to catch it—the typical pattern for an asset where no one knows what the underlying holdings are actually worth.
| Date | Unit Price | Change |
|---|---|---|
| 06/26 | R$ 27.42 | — |
| 07/01 | R$ 23.01 | -16.1% |
| 07/10 | R$ 21.80 | -5.3% |
| 07/14 | R$ 20.16 | -7.5% |
| 07/16 | R$ 18.60 | -7.7% |
| 07/20 | R$ 18.13 | -2.5% |
The acceleration coincides with a compounding series of crises: BRL Trust's resignation on 07/07 (disclosed in a material fact on 07/10), the upcoming unitholder meeting (AGC) to elect a new administrator without a confirmed date, the Helvetia CRI in default since 05/22 (R$ 58.9M, 12.3% of NAV), and Valor Investe's report (05/27) revealing that 100% of the CRI portfolio is under renegotiation or execution. Add to this the fraud allegations filed with federal prosecutors (MPF), federal police (PF), central bank (BCB), securities regulator (CVM), stock exchange (B3), and market self-regulator (BSM), RSM's disclaimer of opinion on the 2025 financial statements, and an accounting loss of R$ 18.9M for the year.
Question 1: Is R$ 18 Cheap or a Trap?
It depends entirely on one question: is the book value of R$ 98.87 real? A paper FII is only worth its CRIs. If the CRIs are worth what the balance sheet says, R$ 18 is a historic bargain. If they aren't, the "discount" is an accounting illusion.
The fund's cash position stood at R$ 2.82M as of March 2026—insufficient for any distributions. Its value lies entirely in the CRIs, and it is precisely the CRI portfolio that is under fire: 58% of NAV (≈ R$ 278M) is concentrated in three Bahian CRIs (Santo André, Amalfi, Savoie) tied to the Sian/Kahhu construction chain. Santo André alone accounts for 27.5% of the debt and, according to unitholders, has an unfiled project and an expired license.
Stress scenarios for NAV itself:
- If the 3 Bahian CRIs (58% of NAV) recover only 50% of collateral over 24-36 months, the real NAV drops to the R$ 60–65 per unit range.
- If Santo André (27.5% of debt) is confirmed as fraud, as unitholders allege, that portion could go to zero, pushing real NAV down to R$ 40–50 per unit.
- If there is a chain default among the Bahian assets, real NAV could fall below R$ 200M.
Conclusion for Question 1: R$ 18 is neither obviously cheap nor obviously a trap—it is a bet on the recovery rate of collateral under judicial execution. Anyone buying here is betting that actual recoveries will exceed the ~20% already priced in. That is not impossible, but it is a gamble, not a value investment with a margin of safety.
Question 2: What Is the Fair Value Range?
There is no single figure. There is a distribution of scenarios—and fair value is their probability-weighted average. Below are the three scenarios that underpin our range.
| Scenario | Prob. | Core Premise | Fair Value |
|---|---|---|---|
| Optimistic | 15% | Fraud unconfirmed; new CRIs issued; AGC elects a solid administrator; collateral executed with ~70% recovery over 36 months. | R$ 30–45 |
| Base | 45% | Partial fraud (Santo André compromised); Bahian assets recover 50–60%; Helvetia executes in 24 months with 60% recovery; P/B of 0.25–0.30 for 12 months. | R$ 20–28 |
| Pessimistic | 40% | Santo André confirmed as fraud; chain default on Bahian assets; real NAV below R$ 200M. | R$ 8–12 |
Note the 40% weighting assigned to the pessimistic scenario. That is the difference between an FII undergoing restructuring and one at risk of permanent destruction: the downside tail is heavy. At R$ 18, the price sits between the upper bound of the pessimistic scenario and the lower bound of the base scenario—meaning the market is already pricing in an environment between "bad" and "very bad." For a buyer at R$ 18 to make money, the base or optimistic scenario must materialize; to lose money, only the pessimistic scenario needs to play out, which currently stands as the most likely standalone outcome.
Question 3: What Should I Do with My Position?
The answer depends on position size and cost basis—not emotion.
The most common mistake here is falling into the sunk cost fallacy: "I won't sell because I've already lost too much." What you paid is unrecoverable and irrelevant to today's decision. The only valid question is: with the money this position is worth right now—R$ 18 per unit—would you buy CACR11? If the answer is no, holding is the same decision as buying. If yes, you understand the risk and accept the bet.
Question 4: When Will Distributions Resume?
Without forced optimism: there is no timeline. Cash stands at R$ 2.82M, and distributions will only resume once an asset generates cash flow. Potential sources and timelines:
| Cash Source | NAV Weight | Estimated Timeline |
|---|---|---|
| Station Vila Madalena (Habite-se issued 04/27, amortizing) | ≈ 3.6% | Q2/Q3 2026 — ~3.6% relief |
| Bahian CRIs (collateral recovery) | ≈ 58% | 12–24 months (optimistic scenario) |
| Helvetia CRI (judicial execution) | ≈ 12.3% | 18–36 months judicial timeline |
Question 5: Does a New Administrator Change the Game?
Yes and no—and the distinction matters. A new administrator can execute collateral more efficiently, call unitholder meetings for transparency, and restore credibility with unitholders and the market. That improves process. What it cannot do is turn troubled projects into healthy CRIs. If Santo André is fraud, no administrator swap undoes that hole.
The decisive signal to watch is not whether there will be a new administrator, but who accepts the role. A reputable institution taking over after serious due diligence is a positive sign—it means someone with a reputation to protect looked at the portfolio and decided it's worth the risk. If only unknown boutiques apply, it means the market is signaling that no established name wants to touch it. Approach the upcoming unitholder meeting with that filter.
Verdict: SELL — Rating 1.0
At R$ 18.13, CACR11 is no longer "cheap on a P/B basis"—it is an asset whose price virtually matches the collateral recovery projected by the market itself. The R$ 98.87 book value is illusory while 100% of the portfolio is under stress, with one CRI in judicial execution (Helvetia) and another facing fraud allegations (Santo André). Fair value ranges from R$ 8–12 (pessimistic, 40%) to R$ 30–45 (optimistic, 15%), anchored around a base case of R$ 20–28—but the highest standalone probability belongs to the bad scenario. No distributions for 6 to 12 months in the best case. For those with large positions, trimming is reasonable. For those who bought at R$ 100+, decide based on the future, not your average cost. For outsiders thinking of "buying the dip": understand that this is a gamble, not value investing. The income thesis is broken; what remains is a multi-year legal dispute with an uncertain outcome.
Sources: CVM Material Fact (Oct 7, 2026), Valor Investe (05/27/2026), CACR11 2025 financial statements (RSM audit), internal fund price and asset data (07/20/2026).
